HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The assessment in sheep of an inactivated vaccine of parainfluenza 3 virus incorporating double stranded RNA (BRL 5907) as adjuvant.

Abstract
The serological responses of conventionally reared sheep were compared after vaccination with inactivated parainfluenza 3 (PI3) virus incorporated in three different adjuvants. Inactivated PI3 virus with the double-stranded RNA, BRL 5907 in an oil emulsion was shown to stimulate higher serum antibody titres over the first 5 weeks after vaccination than virus with and without BCG emulsified in oil. The ability of this vaccine to protect specific pathogen-free lambs against challenge with PI3 virus was examined in a second experiment. In this experiment the vaccine stimulated virus neutralizing and haemagglutination inhibiting antibodies in the serum. After intranasal and intratracheal inoculation with PI3 virus at challenge, vaccinated lambs showed no clinical illness and virus isolation was confined, except in one lamb, to the first two days. In contrast, unvaccinated lambs developed respiratory disease and virus was isolated daily for 7 days after challenge.
AuthorsP W Wells, J M Sharp, C Burrells, B Rushton, W D Smith
JournalThe Journal of hygiene (J Hyg (Lond)) Vol. 77 Issue 2 Pg. 255-61 (Oct 1976) ISSN: 0022-1724 [Print] England
PMID185290 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Adjuvants, Immunologic
  • Antibodies, Viral
  • BCG Vaccine
  • Viral Vaccines
  • RNA
  • Freund's Adjuvant
Topics
  • Adjuvants, Immunologic
  • Animals
  • Antibodies, Viral (analysis)
  • BCG Vaccine
  • Freund's Adjuvant
  • Mycobacterium bovis
  • Nasopharynx (microbiology)
  • Parainfluenza Virus 3, Human (immunology, isolation & purification)
  • RNA
  • Respirovirus (immunology)
  • Sheep
  • Viral Vaccines (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: